Objective: People with borderline personality disorder (BPD) are at high risk for attempting suicide. There are some data to suggest that risk factors for suicide attempts change over time. We conducted a prospective cohort study to examine risk factors for suicide attempts in a treated sample of patients with BPD.
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Clinical Implications
• Suicide attempts are common among BPD patients receiving indicated psychosocial treatments.
• The strongest predictors of suicide attempts in treated patients with BPD were nonmodifiable risk factors.
• Empirically tested psychosocial treatments for BPD may lessen the impact of poor psychosocial functioning or psychopathology on risk of suicide.
Limitations
• Our method of ascertaining suicide attempt status in the follow-up period may have misclassified some participants as nonattempters.
• We only examined baseline assessment measures as risk factors in this investigation.
• Study results cannot generalize to patients receiving other types of empirically derived treatments for BPD.
B
orderline personality disorder is a common, yet frequently lethal, condition owing to the high rate of suicide. Depending on the study, the lifetime risk of suicide in patients with BPD is anywhere between 3% to 10 %, 1 which translates into a mortality rate from suicide in excess of 50 times that of the general population. 2 A history of suicidal behaviour is found in 60% to 70% of patients with BPD, with an even higher percentage engaging in SIBs. 2 Among the few psychosocial interventions that have been shown in RCTs to reduce suicidal behaviour in people with BPD are DBT and GPM, which is a psychodynamic psychotherapy integrated with case management and symptom-targeted psychopharmacological treatment. 3 While DBT has arguably the most empirical support among all forms of psychotherapy for its efficacy in decreasing suicidal behaviour, [4] [5] [6] a recent RCT conducted by our research team (see McMain et al 7 ) found no between-group difference in the frequency and severity of suicidal behaviours and nonsuicidal self-harm episodes among patients who received either GPM or DBT. We concluded that people with BPD could benefit from specific, specialized interventions like DBT and GPM, as participants in both groups experienced a reduction in the frequency and severity of their suicidal behaviours, compared with pre-study, baseline levels.
The field of BPD research has benefited enormously from carefully conducted longitudinal investigations documenting the natural history of the illness. Both the Collaborative Longitudinal Personality Disorders Study 8 and McLean Study of Adult Development 9 have followed their respective cohorts of patients with BPD for more than 10 years each. While these investigations have yielded a wealth of data on clinical predictors of suicidal behaviour in BPD, 10-12 they do not address whether risk factors for suicidal behaviour change with time. One review 13 identified the strongest predictors of suicide attempts in BPD as a history of suicide attempts, childhood sexual abuse, and psychiatric hospitalization, as well as a low Social Adjustment Scale score. To our knowledge, Soloff and Fabio 14 have conducted one of the only prospective investigations of risk factors for suicide attempts in BPD and their stability over time. They found that a suicide attempt in the first 12 months of their 5-year follow-up predicted subsequent attempts during the intervening 4 years. While comorbid MDD emerged as the best predictor of suicidal behaviour in the short term (for example, first 12 months), it did not increase the risk for suicide attempts during the long-term interval (for example, 2 to 5 years). Conversely, poor social adjustment at baseline conferred an elevated risk of suicide throughout the study's 5-year follow-up period. In the Soloff and Fabio study, 14 not all participants had been receiving treatment during the study. Importantly, participants who received outpatient psychiatric treatment showed a reduced risk of suicide attempts in both the shortand long-term intervals. Our investigation is a logical extension of Soloff and Fabio's 14 work that aims to identify prospective risk factors for suicide attempts in a sample of patients with BPD who were enrolled in an RCT designed to compare 1 year of DBT or GPM. We anticipated that delivery of specific manualized treatments for BPD would decrease the Résultats : Presque 26 % des participants ont fait une tentative de suicide durant la phase de traitement d'un an, tandis que 16,7 % ont déclaré une tentative de suicide durant la période de suivi de 2 ans. Le nombre de tentatives de suicide au départ, durant les 4 mois précédant l'étude, et la gravité de l'abus sexuel durant l'enfance prédisaient les tentatives de suicide durant l'année du traitement. De même, les tentatives de suicide au départ, la gravité de l'abus sexuel durant l'enfance, et le nombre d'hospitalisations dans les 4 mois précédant l'étude prédisaient les tentatives de suicide durant le suivi de 2 ans.
Conclusions : Les facteurs de risque des tentatives de suicide dans cet échantillon de patients traités pour le TPL étaient assez stables, largement non modifiables, et non reliés à la psychopathologie ou au fonctionnement psychosocial de départ.
impact of modifiable clinical variables, such as comorbid psychiatric conditions, on risk of suicide attempts.
Methods
In the original study, 7 180 adults meeting DSM-IV 15 criteria for BPD were randomized to 1 year of either DBT treatment (n = 90) or GPM treatment (n = 90). Participants had to be between the ages of 18 and 60 years and had to have at least 2 episodes of suicidal or nonsuicidal self-injurious episodes in the past 5 years, with at least 1 episode occurring in the past 3 months. Exclusion criteria included substance dependence in the preceding 30 days; a diagnosis of psychotic disorder, bipolar I disorder, delirium, dementia, or mental retardation; a medical condition that precluded psychiatric medications; a serious medical condition requiring hospitalization within the next year; living outside of a 40-mile radius of Toronto; and having plans to leave the province in the next 2 years. After 1 year of treatment, all subjects were followed during a 24-month naturalistic posttreatment follow-up, regardless of whether they had completed treatment. The treatments received by participants during the 24-month posttreatment follow-up are documented in McMain et al. 16 The proportion of participants using psychosocial treatments ranged from 51.1% to 62.1% in the DBT group and from 54.2% to 58.6% in the GPM group across the follow-up period. Assessments were conducted at baseline, every 4 months during the treatment phase (that is, 4, 8, and 12 months), and every 6 months for 2 years (18, 24, 26 , and 36 months) after completion of the year of treatment. Assessments were conducted by a board-certified psychiatrist and doctorallevel clinicians who were blinded to treatment group. The study was conducted at 2 University of Toronto teaching hospitals, and the study protocol was approved by each hospital's Research Ethics Board. Participants provided written informed consent for follow-up prior to enrolment in the original study. Participants were compensated $10 per hour for completion of each assessment. The primary outcome measures were the frequency and severity of suicidal and nonsuicidal SIBs, and these behaviours were assessed using a semi-structured interview, the SAS-II. 17 This semi-structured instrument has excellent interrater reliability (0.85 to 0.98) 17 and has been used in several publications on DBT. 5, 6, 18 To determine whether any of the participants who failed to complete the 36-month follow-up assessment had died by suicide, the Ontario provincial death registry was searched. Participants were classified into either a suicide attempt group or a no suicide attempt group, depending on their outcomes during the 1-year treatment phase and 2-year follow-up. Based on their self-report on the SAS-II, 17 the suicide attempt group included participants having engaged in suicidal behaviour with ambivalent, serious, or extreme intent; the no suicide attempt group consisted of participants who had no suicidal behaviour events or, alternatively, had engaged in suicidal behaviour without the intent to die. For the outcome measure of lethality of attempts, the rating of medical risk of death taken from the SAS-II 17 was used. Missing follow-up assessments were dealt with by considering these participants as having had no suicide attempts. By assigning these participants to the no suicide attempt group, our intention was to create a conservative bias, as some of the missing assessments likely included people with suicide attempts. During the 2 years of followup, all participants were only asked about suicide attempts within the last 4 months of the 6-month follow-up period. This approach to our follow-up assessments was done for 2 reasons: first, the 4-month follow-up assessment period was consistent with the 4-month period that was used during the 1-year treatment phase; second, we were concerned that participants could not reliably recall suicidal behaviours that had occurred 5 to 6 months prior to the assessment. Therefore, the rates of suicide attempts during followup periods potentially underestimate all possible suicide attempts but are relevant to the classification of participants into the 2 groups. The 2 groups were compared on characteristics captured as part of their baseline assessments: demographics (age, sex, and marital status); current diagnoses (MDD, substance abuse, PTSD) as assessed by the Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition 19 and antisocial personality disorder, taken from International Personality Disorder Examination, 20 which, in the original study, was used to assess all Axis II disorders; clinical state (BDI, 21 the STAXI) 22 as a measure of impulsivity, and the Social Adjustment Scale-Self-Report 23 ); history of childhood sexual abuse as measured by the sexual abuse subscale score from the CTQ 24 ; suicidal history (the number of suicide attempts in the last 4 months prior to study entry, medical risk highest rating at baseline, and suicide intent highest rating at baseline); and the number of psychiatric hospitalizations in the last 4 months as assessed by the Treatment History Interview. Continuous variables were compared using Student t test (2-tailed) and categorical variables were assessed using chi-square tests. From the univariate analyses, all variables were included as independent variables for a final logistic regression analysis. Given our independent variables included 6 different components, the level of significance was adjusted for the univariate analysis to correct for multiple testing; P value was adjusted to 0.008 (0.05/6 components). For the final multiple regression analysis, we treated the rating of medical risk of death as a continuous variable (range from 1 to 6), and used this score as the dependent variable in the multiple regression analysis. Separate analyses were carried out to examine prospective risk factors after 1 year of treatment and after 2 years of follow-up. 
Results
Among
16
Characteristics of the original 180 participants are described in detail elsewhere. 7, 16 Briefly, participants averaged 30.4 years of age (SD 9.9), were mostly female (86.1%), unemployed (65.0%), and had a college education (42.2%). With 1 exception, there were no differences in demographic, diagnostic, or suicidal and nonsuicidal SIBs at baseline between participants who attended 1 or more follow-up and those lost to follow-up: the prevalence of cluster C personality disorders were higher in participants who attended 1 or more follow-up assessments than those lost to follow-up (44.0%, compared with 23.3%; P = 0.04). The frequency of suicidal and nonsuicidal SIBs by treatment groups was analyzed using generalized estimating equations. 7 The effects of both treatments indicated significant decreases in the frequency and severity of these behaviours during the 1 year of treatment and 2 years of follow-up, with no between-group differences in these outcomes. 7, 16 Given that there were no differences in these outcomes across the 2 treatment groups, the rest of the analyses are performed on the combined sample. Using the definitions of suicide attempts as outlined above, there were 146 (81.1%) participants who reported making at least 1 suicide attempt during their lifetime, 74 (82.2%) in the DBT treatment, and 72 (80.0%) in the GPM treatment group. Among these attempters, 70 (38.9%) participants reported having made a suicide attempt in the 4-month period before study entry, and there were equal numbers (n = 35) in each treatment group. During the 1-year treatment phase, 46 (25.6%) participants reported a suicide attempt and 30 (16.7%) participants engaged in a suicide attempt during the 2-year follow-up period. No participants died from suicide during the course of the 1-year treatment phase or 2-year follow-up. There were 2 deaths owing to natural causes during the study, both in participants who had been assigned to DBT. After completing the univariate analyses of the prospective risk factors (Table 1) , all independent variables were included in a logistic regression to predict suicide attempts, compared with no suicide attempts, during the 1-year treatment phase. Table 1 indicates that 2 independent variables entered the model: log-adjusted count of the number of suicide attempts in the 4-month prior to study entry, with an odds ratio of 1.43 (95% CI 1.12 to 1.82; P = 0.003), and the level of childhood sexual abuse from the CTQ, with an odds ratio of 1.12 (95% CI 1.06 to 1.19; P < 0.001). The same steps were done to examine predictors of suicide attempts during the 2 years of follow-up. Table 2 summarizes the 3 variables that significantly contributed to predicting suicide attempts, compared with no suicide attempts, during the 2 years of follow-up; the variables were log-adjusted counts of the number of suicide attempts in the 4-months prior to study entry, with an odds ratio of 1.88 (95% CI 1.34 to 2.64; P < 0.001), the severity of childhood sexual abuse from the CTQ, with an odds ratio of 1.14 (95% CI 1.05 to 1.24; P = 0.001), and the number of hospitalizations during the last 4 months prior to the baseline assessment, with an odds ratio of 3.34 (95% CI 1.06 to 10.57; P = 0.04). In terms of maximum medical lethality of attempts after the 1-year treatment phase (Table 3) , all the independent variables were entered into a multiple regression analysis. The only variable to significantly contribute to the model was the highest level of medical risk of attempts at the baseline assessment (β = 0.24; F = 5.93, df = 8/105; P = 0.02; R 2 = 0.05). At 2 years follow-up using a similar analytic approach (Table 4) , the log-adjusted count of the number of suicide attempts during the 4-months prior to study entry was a significant predictor in the model (β = 0.25; F = 5.30, df = 7/61, P = 0.02; R 2 = 0.07).
Discussion
We present 1 of the few prospective studies of risk factors for future suicide attempts in a sample of patients with BPD who received 1 year of a specific form of manualized treatment delivered by trained clinicians with expertise in suicide and BPD. Most previous studies have been naturalistic cohort studies, and the nature of the exposure to treatment has been uncontrolled and poorly characterized. 8, 9 Despite of this important difference, the rate of suicide attempts as captured in our assessments seemed roughly comparable with the rates reported by Soloff and Fabio. 14 Our study found that 25.6% of participants attempted suicide during the course of 1 year of treatment and 16.7% of participants during the course of 2 years of follow-up; these rates are somewhat comparable to Soloff and Fabio 14 who reported that 19% of their sample attempted suicide after 1 year of follow-up and 24.8% at 2 years of followup. Participants in the Soloff and Fabio study, 14 may have been less at risk for recurrent suicidal behaviour, because inclusion in their cohort did not require a previous history of self-harm or suicidal behaviour, and almost 30% of that sample was made up of nonpatient volunteers.
The predictive risk factors for suicide attempts with intent during the 1-year treatment phase and 2 years of follow-up include well-recognized risk factors for suicidal behaviour: a history of recent attempts, a history of childhood sexual abuse, and a history of recent frequent hospitalizations. When these risk factors are compared with those found by Soloff and Fabio, 14 some important similarities and differences are noted. At 1-year follow-up, Soloff and Fabio 14 found that comorbid MDD and poor social adjustment predicted the occurrence of suicide attempts. In our sample of participants receiving indicated treatment, comorbid MDD and social adjustment were not significant predictive factors. During 2 years of follow-up, Soloff and Fabio 14 reported that poor social adjustment and a hospitalization prior to any attempt were predictive of attempts at follow-up. With more than 2 to 5 years of follow-up, this group reported that hospitalizations and outpatient medication visits prior to an attempt, a suicide attempt in the first year of followup, and lower Global Assessment Scale score all predicted suicide attempts during the longer period of follow-up. At 6 years follow-up, psychosocial and global functioning continued to be predictors of suicide attempts. 25 Our results were similar in that the number of suicide attempts in the 4 months prior to study entry and hospitalizations were predictive of suicide attempts in our sample receiving specific forms of treatment for BPD. However, some of the potentially modifiable risks, such as comorbid MDD and poor social adjustment, were not significant risk factors in our participants. In fact, in our treated sample, all of the risk factors were essentially nonmodifiable factors. In terms of predicting lethality of attempts, the highest medical lethality of an attempt at baseline predicted future lethality during the 1-year treatment phase. During the follow-up period, the number of suicide attempts during the noted that a rate of 10% has been confirmed in several cohorts, including a 15-year follow-up from the New York Psychiatric Institute and a follow-up of patients for more than 15 to 27 years at a Montreal general hospital. However, lower rates appear to be found among patients who agreed to be followed and who received regular outpatient treatment. Thus these patients may be at a much lower risk of dying by suicide. Perry et al 27 in their follow-up study of former patients at the Austen Riggs Center observed that none of their 92 patients with BPD died by suicide during their 7 years of follow-up. In our study comparing 2 specific forms of treatment for BPD, no suicides were observed during the 3 years of study, which again suggests that the lower lifetime rate of 3% may be more accurate for patients receiving BPD-specific treatments. Our study has some potential implications for clinical practice. Patients with BPD receiving specific forms of manualized treatment are still at risk for subsequent suicide attempts with intent. However, specific forms of treatment may lessen the effects of modifiable risk factors. Nonetheless, nonmodifiable risk factors remain highly relevant to the care of these high-risk patients. In particular, clinicians should always conduct a thorough history of previous attempts, particularly recent attempts, and become very familiar with the number, the level of intention, and the level of lethality demonstrated in previous attempts. Patients with a history of recent attempts, recent hospitalizations, and severe childhood sexual abuse should be closely monitored as outpatients. Extra efforts should be made to prevent these patients from having access to means of suicide, such as large amounts of prescription medication. The history of recent hospitalizations is probably a marker of severity in these patients; however, this risk factor serves as a reminder that patients with BPD are at risk for suicide attempts during hospitalizations and immediately on discharge from an inpatient setting. 28 We must also acknowledge several limitations of our study. First, our follow-up procedures did not allow us to ascertain all of the suicide attempts that may have occurred during the follow-up period, because participants missed followup assessments and we only inquired about the preceding 4 months at each of the 6-month follow-up sessions. To maintain a conservative bias, we assigned the participants with missing data to the nonattempter group, but the true status regarding suicide attempts was unknown. Second, we only used baseline variables as risk factors for prediction of suicide attempts during the follow-up period. In future studies, it would be useful to reassess the psychopathology of participants more proximal to their follow-up assessments. Recently, Wedig et al 29 examined baseline and time-varying predictors of suicide attempts during 16 years follow-up of a naturalistic study of former inpatients with BPD and found a complex array of co-occuring disorders, co-occuring symptoms, adult sexual assault, and a family history of suicide-predicted suicide attempts in this cohort. Third, our study results cannot be generalized to patients receiving other empirically based treatments for BPD, such as mentalized-based treatment. 30 Finally, the outcomes related to suicide attempts were only based on self-report data and future studies might benefit from supplementing self-report data with service contact data.
Conclusions
Our prospective study of risk factors for future suicide attempts in a sample of patients with BPD who received specific forms of psychosocial treatments for the condition has advanced our understanding of suicide risk in these patients. In treated patients, well-established risk factors for suicide and suicidal behaviour, such as a history of recent attempts and hospitalizations and a history of childhood sexual abuse, continue to be important predictors. Specific forms of treatment for BPD may lessen the effects of modifiable risk factors. However, nonmodifiable risk factors remain highly relevant and should be considered when caring for these high-risk patients.
